| Chemical and biotechnological developments in organotin cancer chemotherapy S Tabassum, C Pettinari Journal of Organometallic Chemistry 691 (8), 1761-1766, 2006 | 273 | 2006 |
| Synthesis, characterization and interaction studies of copper based drug with human serum albumin (HSA): spectroscopic and molecular docking investigations S Tabassum, WM Al-Asbahy, M Afzal, F Arjmand Journal of Photochemistry and Photobiology B: Biology 114, 132-139, 2012 | 209 | 2012 |
| Mixed-ligand Cu (II)–vanillin Schiff base complexes; effect of coligands on their DNA binding, DNA cleavage, SOD mimetic and anticancer activity S Tabassum, S Amir, F Arjmand, C Pettinari, F Marchetti, N Masciocchi, ... European Journal of Medicinal Chemistry 60, 216-232, 2013 | 164 | 2013 |
| Synthesis and characterization of copper (II) and zinc (II)-based potential chemotherapeutic compounds: their biological evaluation viz. DNA binding profile, cleavage and … S Tabassum, A Asim, F Arjmand, M Afzal, V Bagchi European journal of medicinal chemistry 58, 308-316, 2012 | 137 | 2012 |
| Interaction and photo-induced cleavage studies of a copper based chemotherapeutic drug with human serum albumin: spectroscopic and molecular docking study S Tabassum, WM Al-Asbahy, M Afzal, F Arjmand, RH Khan Molecular BioSystems 8 (9), 2424-2433, 2012 | 134 | 2012 |
| Organo-tin antitumor compounds: Their present status in drug development and future perspectives F Arjmand, S Parveen, S Tabassum, C Pettinari Inorganica Chimica Acta 423, 26-37, 2014 | 130 | 2014 |
| Advancement of metal compounds as therapeutic and diagnostic metallodrugs: Current frontiers and future perspectives I Yousuf, M Bashir, F Arjmand, S Tabassum Coordination Chemistry Reviews 445, 214104, 2021 | 109 | 2021 |
| Current and future potential of metallo drugs: Revisiting DNA-binding of metal containing molecules and their diverse mechanism of action M Zaki, F Arjmand, S Tabassum Inorganica Chimica Acta 444, 1-22, 2016 | 104 | 2016 |
| New modulated design and synthesis of quercetin–Cu II/Zn II–Sn 2 IV scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity S Tabassum, M Zaki, M Afzal, F Arjmand Dalton Transactions 42 (27), 10029-10041, 2013 | 98 | 2013 |
| Mechanistic insights into a novel chromone-appended Cu (II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and … I Yousuf, F Arjmand, S Tabassum, L Toupet, RA Khan, MA Siddiqui Dalton Transactions 44 (22), 10330-10342, 2015 | 97 | 2015 |
| Synthesis and structure elucidation of a copper (II) Schiff-base complex: in vitro DNA binding, pBR322 plasmid cleavage and HSA binding studies S Tabassum, M Ahmad, M Afzal, M Zaki, PK Bharadwaj Journal of Photochemistry and Photobiology B: Biology 140, 321-331, 2014 | 90 | 2014 |
| Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase I inhibitor S Tabassum, WM Al-Asbahy, M Afzal, F Arjmand, V Bagchi Dalton Transactions 41 (16), 4955-4964, 2012 | 90 | 2012 |
| Nuclear blebbing of biologically active organoselenium compound towards human cervical cancer cell (HeLa): In vitro DNA/HSA binding, cleavage and cell imaging studies MA Rizvi, M Zaki, M Afzal, M Mane, M Kumar, BA Shah, S Srivastav, ... European Journal of Medicinal Chemistry 90, 876-888, 2015 | 89 | 2015 |
| Synthesis of new piperazine derived Cu (II)/Zn (II) metal complexes, their DNA binding studies, electrochemistry and anti-microbial activity: Validation for specific … S Tabassum Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 72 (5 …, 2009 | 80 | 2009 |
| Biochemical pathways of copper complexes: Progress over the past 5 years S Zehra, S Tabassum, F Arjmand Drug Discovery Today 26 (4), 1086-1096, 2021 | 79 | 2021 |
| Synthesis and spectroscopic characterization of diorganotin (IV) complexes of N′-(4-hydroxypent-3-en-2-ylidene) isonicotinohydrazide: chemotherapeutic potential validation by … S Yadav, I Yousuf, M Usman, M Ahmad, F Arjmand, S Tabassum RSC Advances 5 (63), 50673-50690, 2015 | 76 | 2015 |
| Synthesis of heterobimetallic complexes: In vitro DNA binding, cleavage and antimicrobial studies S Tabassum, M Zaki, F Arjmand, I Ahmad Journal of Photochemistry and Photobiology B: Biology 114, 108-118, 2012 | 76 | 2012 |
| Interaction of a ruthenium (II)–chalcone complex with double stranded DNA: spectroscopic, molecular docking and nuclease properties R Gaur, RA Khan, S Tabassum, P Shah, MI Siddiqi, L Mishra Journal of Photochemistry and Photobiology A: Chemistry 220 (2-3), 145-152, 2011 | 73 | 2011 |
| Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action S Parveen, F Arjmand, S Tabassum European Journal of Medicinal Chemistry 175, 269-286, 2019 | 68 | 2019 |
| Synthesis and characterization of Cu(II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: In vitro DNA binding, pBR322 cleavage, molecular … S Tabassum, M Zaki, M Afzal, F Arjmand European journal of medicinal chemistry 74, 509-523, 2014 | 68 | 2014 |
Dr. Rais Ahmad KhanAssociate Professor, Department of Chemistry, King Saud Universityبريد إلكتروني تم التحقق منه على KSU.EDU.SA
